King Wealth Eli Lilly & CO Transaction History

King Wealth

$642 Million
Q3 2024

A detailed history of King Wealth transactions in Eli Lilly & CO stock. As of the latest transaction made, King Wealth holds 25,480 shares of LLY stock, worth $20.3 Million. This represents 3.52% of its overall portfolio holdings.

Number of Shares

25,480

Previous 25,423 0.22%

Holding current value

$20.3 Million

Previous $23 Million 1.92%

% of portfolio

3.52%

Previous 3.84%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$772.14 - $960.02 $44,011 - $54,721	57 Added 0.22%	25,480 $22.6 Million
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $129,026 - $161,809	-178 Reduced 0.7%	25,423 $23 Million
Q1 2024 May 09, 2024	BUY	$592.2 - $792.28 $154,564 - $206,785	261 Added 1.03%	25,601 $19.9 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $3.74 Million - $4.41 Million	7,126 Added 39.12%	25,340 $14.8 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $1.39 Million - $1.92 Million	-3,202 Reduced 14.95%	18,214 $9.78 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $288,659 - $385,970	-823 Reduced 3.7%	21,416 $10 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $1.16 Million - $1.36 Million	3,722 Added 20.1%	22,239 $7.64 Million
Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $60,772 - $70,812	189 Added 1.03%	18,517 $6.77 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $785,672 - $895,355	2,650 Added 16.9%	18,328 $5.93 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $2.38 Million - $2.79 Million	8,538 Added 119.58%	15,678 $5.08 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $1.19 Million - $1.48 Million	-5,060 Reduced 41.48%	7,140 $2.05 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $226,648 - $281,272	1,008 Added 9.01%	12,200 $3.37 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $8,864 - $10,908	-40 Reduced 0.36%	11,192 $2.59 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $1,643 - $2,127	-10 Reduced 0.09%	11,232 $2.1 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $331,368 - $438,480	2,540 Added 29.19%	11,242 $1.9 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $438,660 - $507,390	3,000 Added 52.61%	8,702 $1.29 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $409,259 - $492,540	3,000 Added 111.03%	5,702 $936,000
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $5,559 - $6,886	52 Added 1.96%	2,702 $355,000
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $5,565 - $6,570	-75 Reduced 2.75%	2,650 $205,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,725	2,725 $224,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

News

Stay updated on King Wealth with notifications on news.

Account